Stock Taper 
ADAR1 CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Royalty Pharma plc | RPRX | 12.5K | $700.88K |
 Bicara Therapeutics Inc. Common Stock | BCAX | 13.71K | $406.9K |
 Tectonic Therapeutic, Inc. | TECX | 14.5K | $498.47K |
 Entrada Therapeutics, Inc. | TRDA | 15.5K | $114.08K |
 Krystal Biotech, Inc. | KRYS | 16.42K | $6.1M |
 Biogen Inc. | BIIB | 17.9K | $3.87M |
 Vera Therapeutics, Inc. | VERA | 18.32K | $786.2K |
 Alexandria Real Estate Equities, Inc. | ARE | 19.5K | $1.03M |
 IDEAYA Biosciences, Inc. | IDYA | 20K | $745.4K |
 Oruka Therapeutics, Inc. | ORKA | 20.84K | $1.98M |
 Regeneron Pharmaceuticals, Inc. | REGN | 22.21K | $13.85M |
 OrthoPediatrics Corp. | KIDS | 25K | $478.25K |
 Danaher Corporation | DHR | 25.93K | $4.94M |
 Seaport Therapeutics, Inc. Common Stock | SPTX | 26K | $564.72K |
 MapLight Therapeutics, Inc. | MPLT | 26.5K | $949.65K |
 Kiniksa Pharmaceuticals International, plc | KNSA | 26.91K | $1.72M |
 Novo Nordisk A/S | NVO | 27K | $1.29M |
 MoonLake Immunotherapeutics | MLTX | 27K | $525.69K |
 Supernus Pharmaceuticals, Inc. | SUPN | 27.84K | $1.29M |
 Ascendis Pharma A/S | ASND | 28.6K | $7.63M |